Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Imran G House

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
The FEBS Journal|March 24, 2018
Tumor-derived exosomes modulate T cell function through transfer of RNAImran G House, Emma V Petley, Paul A Beavis
Immunology and Cell Biology|March 21, 2022
CD4<sup>+</sup> chimeric antigen receptor T cells in for the long journeyAmanda Xy Chen, Emily B Derrick, Paul A Beavis, et al.
Oncoimmunology|September 14, 2016
Missense mutations in the perforin (PRF1) gene as a cause of hereditary cancer predispositionMohammed S Chaudhry, Kimberly C Gilmour, Imran G House, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 29, 2014
A method for detecting intracellular perforin in mouse lymphocytesAmelia J Brennan, Imran G House, Jane Oliaro, et al.
Immunology and Cell Biology|March 18, 2015
Heterozygosity for the common perforin mutation, p.A91V, impairs the cytotoxicity of primary natural killer cells from healthy individualsImran G House, Kevin Thia, Amelia J Brennan, et al.
EMBO Reports|August 16, 2017
Regulation of perforin activation and pre-synaptic toxicity through C-terminal glycosylationImran G House, Colin M House, Amelia J Brennan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 11, 2020
Efficient CRISPR/Cas9 Gene Editing in Uncultured Naive Mouse T Cells for In Vivo StudiesSimone Nüssing, Imran G House, Conor J Kearney, et al.
Clinical & Translational Immunology|November 27, 2019
Tissue-specific tumor microenvironments influence responses to immunotherapiesAmanda J Oliver, Ashleigh S Davey, Simon P Keam, et al.
Clinical Epigenetics|July 28, 2022
Distinct modulation of IFNγ-induced transcription by BET bromodomain and catalytic P300/CBP inhibition in breast cancerSimon J Hogg, Olga Motorna, Conor J Kearney, et al.
Cancer Immunology Research|July 19, 2018
Dual PD-1 and CTLA-4 Checkpoint Blockade Promotes Antitumor Immune Responses through CD4<sup>+</sup>Foxp3<sup>-</sup> Cell-Mediated Modulation of CD103<sup>+</sup> Dendritic CellsPaul A Beavis, Melissa A Henderson, Lauren Giuffrida, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
The FEBS Journal|March 24, 2018
Tumor-derived exosomes modulate T cell function through transfer of RNAImran G House, Emma V Petley, Paul A Beavis
Immunology and Cell Biology|March 21, 2022
CD4<sup>+</sup> chimeric antigen receptor T cells in for the long journeyAmanda Xy Chen, Emily B Derrick, Paul A Beavis, et al.
Oncoimmunology|September 14, 2016
Missense mutations in the perforin (PRF1) gene as a cause of hereditary cancer predispositionMohammed S Chaudhry, Kimberly C Gilmour, Imran G House, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 29, 2014
A method for detecting intracellular perforin in mouse lymphocytesAmelia J Brennan, Imran G House, Jane Oliaro, et al.
Immunology and Cell Biology|March 18, 2015
Heterozygosity for the common perforin mutation, p.A91V, impairs the cytotoxicity of primary natural killer cells from healthy individualsImran G House, Kevin Thia, Amelia J Brennan, et al.
EMBO Reports|August 16, 2017
Regulation of perforin activation and pre-synaptic toxicity through C-terminal glycosylationImran G House, Colin M House, Amelia J Brennan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 11, 2020
Efficient CRISPR/Cas9 Gene Editing in Uncultured Naive Mouse T Cells for In Vivo StudiesSimone Nüssing, Imran G House, Conor J Kearney, et al.
Clinical & Translational Immunology|November 27, 2019
Tissue-specific tumor microenvironments influence responses to immunotherapiesAmanda J Oliver, Ashleigh S Davey, Simon P Keam, et al.
Clinical Epigenetics|July 28, 2022
Distinct modulation of IFNγ-induced transcription by BET bromodomain and catalytic P300/CBP inhibition in breast cancerSimon J Hogg, Olga Motorna, Conor J Kearney, et al.
Cancer Immunology Research|July 19, 2018
Dual PD-1 and CTLA-4 Checkpoint Blockade Promotes Antitumor Immune Responses through CD4<sup>+</sup>Foxp3<sup>-</sup> Cell-Mediated Modulation of CD103<sup>+</sup> Dendritic CellsPaul A Beavis, Melissa A Henderson, Lauren Giuffrida, et al.
Pageof 3